Welcome : Guest

Synairgen Plc (UK) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Synairgen Plc, which is principally involved in Respiratory Drug Discovery and Development. Illustrated with 12 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-43718
Price: $600
Company Type: Public
Pages: 13
Date: November 2016
Market Data Tables: 12

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Asthma Drugs......2
Table 1: Asthma Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......2
Table 2: No. of Asthma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......3
Table 3: Asthma Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Advair Diskus, Combivent, Proair HFA, Singulair, Spiriva HandiHaler, Symbicort, and Others......4
Chronic Obstructive Pulmonary Disease (COPD) Drugs......5
Table 4: Chronic Obstructive Pulmonary Disease (COPD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......5
Table 5: Chronic Obstructive Pulmonary Disease (COPD) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Long Acting Muscarinic Antagonists (LAMA), Long Acting Muscarinic Antagonists (LAMA) and Long Acting β2-Agonists (LABA), and Long Acting β2-Agonists (LABA) and Inhaled Corticosteroid (ICS)......6
Table 6: No. of Chronic Obstructive Pulmonary Disease (COPD) Patients Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......7
Table 7: Chronic Obstructive Pulmonary Disease (COPD) and Asthma Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......8
Respiratory Drugs......9
Table 8: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......9
Table 9: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......10
Table 10: Respiratory Drugs (Asthama, COPD & Allergic Rhinitis) Market Worldwide (2015) in US$ Million......11
Table 11: Respiratory Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Allegra and Telfast, Claritin and Clarinex, Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......12
Respiratory Therapeutics......13
Table 12: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......13